Immunomodulators regulate the immune system — either suppressing overactive immune responses in autoimmune disease or enhancing immune function in immunodeficiency. Compounded immunomodulators include Low Dose Immunotherapy (LDI), thymosin peptides, and immune-regulating compounds used in integrative medicine.
Depending on the agent, immunomodulators work by desensitizing the immune system to specific antigens (LDI), stimulating T-cell maturation (thymosin alpha-1), blocking inflammatory cytokines, or modulating toll-like receptors (LDN dual-mechanism).
Low Dose Immunotherapy (LDI) requires ultra-dilute preparations of specific antigens compounded by specialized pharmacies. Thymosin peptides, BPC-157, and other immunomodulating peptides are only available through compounding pharmacies.
Immunomodulating peptides like thymosin alpha-1 and BPC-157 are not FDA-approved for general use and are compounded under 503A for patient-specific prescriptions. The FDA has issued guidance restricting certain peptides from compounding. Verify availability with your pharmacy before prescribing.
These compounded medications belong to this drug class. Click any medication to learn more and compare pharmacy prices.
Submit a free quote request and receive pricing from multiple licensed compounding pharmacies within 1–2 business days.
Get Free Quotes.png){kind=spacer}
